World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
68890
World Ranking
3181
National Ranking
320

Overview

Gordon D.O. Lowe is a researcher affiliated with the University of Glasgow in the United Kingdom. The primary field of study is Medicine, with a focus on several subfields including Hematology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Internal Medicine, and Neurology. The scientist has contributed extensively to research on blood coagulation and thrombosis mechanisms, blood properties and coagulation, venous thromboembolism diagnosis and management, intracerebral and subarachnoid hemorrhage, atrial fibrillation management and outcomes, hemophilia treatment, and acute ischemic stroke management.

Recent papers authored or co-authored by Gordon D.O. Lowe include the following publications:

  • Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial (2021, The Lancet Neurology)
  • Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage (2021, JAMA Neurology)
  • Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis (2023, Thrombosis Research)
  • Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D-dimer and APTT as a predictive test for thromboembolism? (2022, British Journal of Haematology)
  • Plasma viscosity, immunoglobulins and risk of cardiovascular disease and mortality: new data and meta-analyses (2023, Journal of Clinical Pathology)

The scientist has collaborated frequently with other researchers, with notable co-authors being:

  • Mark Woodward
  • Ann Rumley
  • Hugh Tunstall-Pedoe
  • Sanne A. E. Peters
  • Rustam Al-Shahi Salman

Gordon D.O. Lowe's publications appear in a variety of academic journals, with the most frequent venues being:

  • The Journal of the Royal College of Physicians of Edinburgh
  • TH Open
  • The Lancet Neurology
  • JAMA Neurology
  • Thrombosis Research

The research topics addressed consistently engage with critical issues in cardiovascular and hematological health, including blood coagulation and thrombosis mechanisms, venous thromboembolism diagnosis and management, intracerebral hemorrhage, atrial fibrillation outcomes, and hemophilia treatment strategies.

Best Publications

  • C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

    John Danesh;Jeremy G Wheeler;Gideon M Hirschfield;Shinichi Eda

  • C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

    S Kaptoge;E Di Angelantonio;G Lowe

  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

    J Danesh;S Lewington;S G Thompson;Lowe Gdo.

  • C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

    Stephen Kaptoge;Emanuele Di Angelantonio;Lisa Pennells;Angela M. Wood

  • Lipoprotein-Associated Phospholipase A2 as an Independent Predictor of Coronary Heart Disease

    Chris J. Packard;Denis S. J. O'reilly;Muriel J. Caslake;Alex D. Mcmahon

  • Thrombophilia in pregnancy: a systematic review

    L. Robertson;O. Wu;P. Langhorne;S. Twaddle

  • The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

    D I Swerdlow;M V Holmes;K B Kuchenbaecker

  • Carotid Plaque, Intima Media Thickness, Cardiovascular Risk Factors, and Prevalent Cardiovascular Disease in Men and Women: The British Regional Heart Study

    Shah Ebrahim;Olia Papacosta;Peter Whincup;Goya Wannamethee

  • C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study

    Dilys J. Freeman;John Norrie;Muriel J. Caslake;Allan Gaw

  • Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.

    John Danesh;Stephen Kaptoge;Andrea G Mann;Nadeem Sarwar

  • HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

    Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  • Inflammatory Cytokines and Risk of Coronary Heart Disease: New Prospective Study and Updated Meta-Analysis

    Stephen Kaptoge;Sreenivasa Rao Kondapally Seshasai;Pei Gao;Daniel F Freitag

  • Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

    G. Eiriksdottir;T. B. Harris;L. J. Launer;V. Gudnason

  • Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome Nested Case-Control Study

    E.J. Brunner;H. Hemingway;B.R. Walker;M. Page

  • Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study

    G. D. O. Lowe;A. J. Lee;A. Rumley;J. F. Price

  • Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men

    S. Goya Wannamethee;Gordon D.O. Lowe;Peter H. Whincup;Ann Rumley

  • Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study

    O. Wu;L. Robertson;S. Twaddle;G. D. Lowe

  • Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.

    D. Gimeno;M. Kivimäki;E. J. Brunner;M. Elovainio

  • Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

    F. Gerald R. Fowkes;Jacqueline F. Price;Marlene C. W. Stewart;Isabella Butcher

  • Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

    Marianne Canonico;Geneviève Plu-Bureau;Gordon D O Lowe;Pierre-Yves Scarabin

Frequent Co-Authors

Ann Rumley
Ann Rumley University of Glasgow
Mark Woodward
Mark Woodward Imperial College London
Peter H. Whincup
Peter H. Whincup St George's, University of London
Naveed Sattar
Naveed Sattar University of Glasgow
Paul Welsh
Paul Welsh University of Glasgow
Amanda J. Lee
Amanda J. Lee University of Aberdeen
David J. Stott
David J. Stott University of Glasgow
Ian Ford
Ian Ford University of Glasgow
Debbie A. Lawlor
Debbie A. Lawlor University of Bristol
Ian J. Deary
Ian J. Deary University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open a wide range of career opportunities beyond a traditional MD. For students interested in leadership and management roles, a bachelors in health administration offers foundational knowledge in healthcare systems, finance, and policy. This path is ideal for those entering healthcare management positions.

Professionals aiming to advance in executive roles should consider enrolling in affordable mha online programs. These programs provide in-depth training in leadership, quality improvement, and strategic planning in healthcare organizations.

For nursing professionals seeking to reach the highest levels of practice, the most affordable dnp programs prepare graduates for advanced clinical roles or leadership positions in nursing practice.

Aspiring pharmacists can enter the field through an online pharmd program. These flexible options enable students to gain expert knowledge in medication therapy management, drug safety, and pharmaceutical research.

Each of these online degree options provides accessible pathways to impactful careers across the healthcare industry.

Best Scientists Citing Gordon D.O. Lowe

Trending Scientists